Keller, Fishback & Jackson LLP files nationwide class action against tire manufacturer for false advertising and unfair business practices.

February 09, 2017

The law firm of Keller, Fishback and Jackson LLP filed a consumer class action on February 9, 2017, on behalf of three consumers and all others similarly situated in U.S. District Court for the Central District of California against TBC Corporation, Dynamic Tire Corporation and Does 1-10, alleging they falsely advertise the reliability of their tires used on trailers and fifth wheels. The case is captioned Hamilton, et al. v. TBC Corporation, et al. (Case No. 2:17-cv-01060).

Man who suffered severe liver and kidney damage sues makers of nutritional supplements

September 02, 2016

The law firm of Keller, Fishback & Jackson LLP is representing a 37-year old father of two young children who suffered serious and life-threatening injuries after using over-the-counter nutritional supplements. Fernando Del Real used two products called Tri-Methyl Xtreme and Liver Health to increase his strength and build muscle.

Gerber Formula Buyers Near Cert. In Allergy False Ad Suit

January 11, 2016

Law360, Los Angeles (January 11, 2016, 9:58 PM ET) -- A California federal judge on Monday tentatively certified a class of potentially thousands of buyers of Gerber Good Start Gentle baby formula who allege the company falsely claimed the product kept babies from developing allergies, saying those who bought formula containing allegedly misleading labeling can proceed together.

Calif. Mother Seeks Class Cert. In Gerber False Ad Suit

October 27, 2015

Law360, New York (October 27, 2015, 12:52 PM ET) -- A mother claiming Gerber duped her into believing its Good Start Gentle baby formula could prevent her daughter from developing allergies asked a federal judge on Monday to certify a class covering thousands of Californians who have bought the formula since 2011.

Gerber Can't Dodge Baby Formula False Advertising Suit

June 19, 2015

Law360, Los Angeles (June 19, 2015, 6:31 PM ET) -- A California federal judge on Thursday denied a bid by Gerber Products Co. to toss a putative class action accusing the baby food maker of falsely advertising a baby formula product, ruling the court has proper jurisdiction over the case.

Keller, Fishback & Jackson LLP files class action suit against Gerber for unsupported claims that its infant formula reduced allergies in babies.

January 09, 2015

(Los Angeles, CA) On January 9, 2015, Los Angeles based Keller, Fishback & Jackson LLP and New York based Squitieri & Fearon, LLP, filed a class action lawsuit in federal district court in the Central District of California against Gerber Products Company, a manufacturer of infant formula. The case is captioned Zakaria v. Gerber Products Co. (Case 2:15-cv 00200).

California Court of Appeal affirms $24 million verdict against supplier of asbestos.

November 12, 2014

In a personal injury lawsuit brought against manufacturers and suppliers of asbestos-containing products, a jury awarded Bobbie Izell $6 million in compensatory damages and $18 in punitive damages. On appeal, Union Carbide, one of the defendants in the case, argued that the evidence was insufficient to support the award. The appellate court however disagreed and affirmed the lower court’s decision.

Biomet subsidiary settles Medicare fraud claims in one out of two lawsuits brought by US government

November 12, 2014

EBI LLC, a subsidiary of medical device manufacturer Biomet Inc., has agreed to pay over $6 million to settle a lawsuit alleging it defrauded Medicare and gave kickbacks to doctors’ offices to encourage sales of its bone growth stimulators.

Power morcellation and the risk of uterine sarcoma dissemination

August 15, 2014

An estimated 50,000 women a year in the United States undergo a hysterectomy (removal of the uterus) or myomectomy (removal of uterine fibroids) with the use of a medical device known as a power morcellator. Power morcellators typically use a rapidly rotating blade to cut (or “morcellate”) fibroids and other tissue into small pieces (approximately 1 cm diameter) that can be removed through small incision sites in a minimally invasive procedure known as laparoscopic surgery.

FDA warns about the risk of uterine cancer following power morcellation.

June 3, 2014

The FDA warns the public that power morcellation for uterine fibroid removal poses an increased risk of spreading cancer, notably uterine sarcomas, beyond the uterus.

Legal Thoughts on the AMS Transvaginal Mesh Settlement

May 22, 2014

As an attorney who has represented women in pharmaceutical and medical device litigation for over thirty years, including DES, fen-phen and breast implants, and who currently represents women injured by transvaginal mesh, I was not surprised to learn that Endo and some of the plaintiff firms had arrived at a mass settlement. After all, in this type of litigation-known as mass torts-mass settlements are not unusual as they can resolve a large number of cases quickly and efficiently.

Hernia mesh lawsuit filed against Atrium Medical Corporation

March 11, 2014

The law firm of Keller, Fishback & Jackson LLP recently filed a lawsuit in California federal court on behalf of a forty-six year old man injured by a hernia mesh product. The lawsuit alleges claims of product liability, negligence, and fraud against Atrium Medical Corporation (Atrium), the mesh manufacturer, and seeks compensatory and punitive damages. This is believed to be the first case in California filed against Atrium for one of its hernia mesh products.

The 510(k) process and the approval of medical devices-safety forgotten

January 23, 2014

The 510(k) process is relied upon by the medical device industry, including pelvic mesh manufacturers, such as Ethicon/Johnson & Johnson, Atrium Medical Corporation, and Davol/Bard, to quickly get devices marketed in the United States. (The term "510(k)" is derived from the statutory section that created the premarket notification process, section 510(k) of the Federal Food, Drug and Cosmetic Act.)

FDA warns about skin reactions with anti-seizure drug Onfi (clobazam)

December 3, 2013

The FDA warns the public that the anti-seizure drug Onfi (clobazam) can cause rare but serious skin reactions that can result in permanent harm and death.

FDA warns about serious complications with metal-on-metal hip implants

January 17, 2013

The FDA informs the public that metal-on-metal hip implants have unique risks, including the release of metal particles into the bloodstream.

FDA provides information on surgical mesh for hernia repair

November 16, 2012

The FDA informs the public about the most common adverse events associated with surgical mesh for hernia repair.

FDA warns about serious complications with transvaginal mesh

July 13, 2011

The FDA informs the public that serious complications associated with transvaginal mesh are not rare.


The Star-Ledger Interviews Daniel Keller About Merck's Witness

This Time It's Asbestos, Not Gold, Found In California Hills and It's Presenting Health Risks To Residents

Proposed Asbestos Legislation Benefits Asbestos Companies and Harms Asbestos Victims

Low Levels of Asbestos Determined To Cause Mesothelioma

First Vioxx® Trial Begins in Texas

Congressional Budget Office Releases Cost Estimate of Asbestos Bill

German Press Interviews Stephen Fishback About First Vioxx Trial

FDA Knew of Guidant Heart Device Failures

Jury Hits Ford Motor Co with $30 Million

Verdict For Faulty Pick-up Truck

Cintas Workers Win Historic Class Action Suit in California

Free Case Evaluation